Jonathan D. Licht, MD, is the Director of the University of Florida Health Cancer Center. Dr. Licht’s laboratory studies the role of abnormal function of histone methyltransferases and demethylases in malignancies such as multiple myeloma and acute lymphoblastic leukemia and recently described a new class of mutations in histones in cancer. NCI funded for 30 years, Dr. Licht is also Principal Investigator of a Leukemia and Lymphoma Society (LLS) Specialized Center of Research and co-leader of the Chicago Region Physical Sciences Oncology Center. He is an Associate Editor of Oncogene and serves on the editorial boards of Cancer Discovery, Cancer Cell, Cancer Research and Clinical Cancer Research. Dr. Licht is chair of the Taskforce for Hematological Malignancies of AACR, and is co-chair of the Medical/Scientific Board of the LLS. Dr. Licht has published more than 200 articles, reviews and book chapters and has mentored over 40 graduate students and postdoctoral fellows and 20 faculty members.